| Authors: |
Najumudeen AK; Cancer Research UK Scotland Institute, Glasgow, UK. arafath.najumudeen@helsinki.fi.; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland. arafath.najumudeen@helsinki.fi., Fey SK; Cancer Research UK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Millett LM; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Ford CA; Cancer Research UK Scotland Institute, Glasgow, UK., Gilroy K; Cancer Research UK Scotland Institute, Glasgow, UK., Gunduz N; Cancer Research UK Scotland Institute, Glasgow, UK., Ridgway RA; Cancer Research UK Scotland Institute, Glasgow, UK., Anderson E; Cancer Research UK Scotland Institute, Glasgow, UK., Strathdee D; Cancer Research UK Scotland Institute, Glasgow, UK., Clark W; Cancer Research UK Scotland Institute, Glasgow, UK., Nixon C; Cancer Research UK Scotland Institute, Glasgow, UK., Morton JP; Cancer Research UK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Campbell AD; Cancer Research UK Scotland Institute, Glasgow, UK. a.campbell@beatson.gla.ac.uk., Sansom OJ; Cancer Research UK Scotland Institute, Glasgow, UK. o.sansom@beatson.gla.ac.uk.; School of Cancer Sciences, University of Glasgow, Glasgow, UK. o.sansom@beatson.gla.ac.uk. |
